Venture capitalists invested $300 million in Maryland companies in 2016, a 70 percent drop from $1 billion the year before.
In the Obama administration’s final days, the National Cancer Institute is establishing an ambitious new program designed to allow scientists to more quickly access new drugs and compounds for novel research.
One of the last achievements of Vice President Joe Biden’s cancer moonshot initiative before he leaves office, the program was unveiled Wednesday and will begin as an agreement between the institute and six drug companies.
The search is on for the Best University Startups of 2017. We are calling all universities and their startups to apply and be considered to present live at the next University Startups Conference and Demo Day on April 18-20, 2017 in Washington, D.C.
The National Council of Entrepreneurial Tech Transfer (NCET2) will hold its second University Startups Demo Day (USDD) at the Washington Convention Center in Washington, DC on April 18-20, 2017.
The DoD SBIR 17.1 & STTR 17.A Broad Agency Announcements are Now Open for Proposal Submission on January 10, 2017
You may now submit your Phase I and Direct to Phase II proposals for the open SBIR 17.1 and STTR 17.A Broad Agency Announcements (BAA) through the DOD SBIR/STTR proposal submission website at https://sbir.defensebusiness.org. All proposals for this Announcement must be received by 6:00 am. ET on Wednesday, February 8, 2017.
Prickly pear trees and the brown seaweed, commonly known as Peacocks tail, are a common sight in the Mediterranean. [Stephanie Ghio] It would seem that Juan Ponce de Leon’s trip to the New World in search of the fountain of youth may have been even more in vain, given that it may have been right in his “backyard.” Evidence from a new study by investigators at the University of Malta and the Centre National de la Recherche Scientifique (CNRS/University of Bordeaux) shows that chemicals in ubiquitous Mediterranean plants could hold the key to delaying age-related diseases.
New East Baltimore Partnership (“FC-NEBP”) and Toshiba Medical Research Institute USA, Inc. (“Toshiba Medical”) announced today that they have executed a lease to construct a medical research center at 1812 Ashland Avenue, the newest building in the Science + Technology Park at Johns Hopkins. When it opens, the Toshiba Medical research center will showcase next-generation technology that will offer a unique opportunity at the Johns Hopkins East Baltimore Medical Campus to collaborate with researchers seeking the most advanced imaging capacity in the world.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
- NIH & AHRQ Update Font Guidelines for Applications to Due Dates On or After
- January 25, 2017
- (NOT-OD-17-030) National Institutes of Health
- Technical Assistance Videocast for RFA RM-16-019 “NIH Health Care Systems Research Collaboratory – Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)”
- (NOT-RM-17-005)
- NIH Roadmap Initiatives
- Notice of Availability of Frequently Asked Questions and a Recording of the Pre-application Webinar on the NIH Illuminating the Druggable Genome (IDG) Program Website for RFA-RM-16-024, RFA-RM-16-025, and RFA-RM-16-026
- (NOT-RM-17-006)
- NIH Roadmap Initiatives
Requests for Applications:
- National Centers for Cryoelectron Microscopy (U24)
- (RFA-RM-17-002)
- NIH Roadmap Initiatives
- Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Program Announcements:
- Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement
- (Admin Supp)
- (PA-17-101)
- Office of Research on Women’s Health
- National Center for Advancing Translational Sciences
- National Eye Institute
- National Human Genome Research Institute
- National Heart, Lung, and Blood Institute
The Pentagon’s research and development division, DARPA—the creative force behind the internet and GPS—retooled itself three years ago to create a new office dedicated to unraveling biology’s engineering secrets. The new Biological Technologies Office (BTO) has a mission to “harness the power of biological systems” and design new defense technology. Over the past year, with a budget of about $296 million, it has been exploring challenges including memory improvement, human–machine symbiosis and speeding up disease detection and response.
Ask anyone to identify Baltimore’s big anchors, and Under Armour and Johns Hopkins will likely appear in the same sentence.
Now the two are teaming up — brought together by tech.
Johnson & Johnson Innovation LLC, New York State and the New York Genome Center today announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in SoHo and will open in 2018. The project is receiving $17 million in New York State funding. The site will be open to biotech, pharmaceutical, medical device and consumer health companies. A QuickFire Challenge seeking companies working in these areas, particularly startups working on cross-sector solutions to prevent, intercept or cure diseases, will be launched by Johnson & Johnson Innovation, with the winner(s) eligible for one year of residency at JLABS @ NYC.